Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fibroma × telapristone acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 10 Breast Neoplasms 2 Fibroma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

Imatinib Mesylate 2 telapristone acetate 1 Specimen Handling 1 Sirolimus 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Hydroxyurea 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02323646 2019-06-25

Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids

Repros Therapeutics Inc.

Phase 2 Completed

42 enrolled 22 charts

Fibroma, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡